Merit Medical Systems Inc (NASDAQ:MMSI) files its latest 10-K with SEC for the fiscal year ended on December 31, 2018. Merit Medical Systems Inc designs, develops, manufactures and sells medical devices used in interventional and diagnostic procedures. Its products are used in thoracic surgery, interventional nephrology, vascular surgery, and oncology and pain management. Merit Medical Systems Inc has a market cap of $3.19 billion; its shares were traded at around $58.16 with a P/E ratio of 75.54 and P/S ratio of 3.64. Merit Medical Systems Inc had annual average EBITDA growth of 6.40% over the past ten years. GuruFocus rated Merit Medical Systems Inc the business predictability rank of 3.5-star.
For the last quarter Merit Medical Systems Inc reported a revenue of $233.2 million, compared with the revenue of $190.9 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $882.8 million, an increase of 21.3% from last year. For the last five years Merit Medical Systems Inc had an average revenue growth rate of 13.9% a year.
The reported diluted earnings per share was 78 cents for the year, an increase of 41.8% from previous year. Over the last five years Merit Medical Systems Inc had an EPS growth rate of 10.2% a year. The Merit Medical Systems Inc had an operating margin of 6.64%, compared with the operating margin of 4.61% a year before. The 10-year historical median operating margin of Merit Medical Systems Inc is 7.75%. The profitability rank of the company is 8 (out of 10).
At the current stock price of $58.16, Merit Medical Systems Inc is traded at 123.3% premium to its historical median P/S valuation band of $26.05. The P/S ratio of the stock is 3.64, while the historical median P/S ratio is 1.64. The intrinsic value of the stock is $8.24 a share, according to GuruFocus DCF Calculator. The stock gained 26.71% during the past 12 months.
For the complete 20-year historical financial data of MMSI, click here.
No comments:
Post a Comment